ARDELYX, INC. — Director's Dealing 2016

Dec 21, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARDELYX, INC. (ARDX)
CIK: 0001437402
Period of Report: 2016-12-16

Reporting Person: Rosenbaum David P. (SVP, Drug Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-16	Common Stock	S	900	$14.4837	Disposed	636	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22144	Direct
Common Stock	77592	Indirect

Footnotes

F1: The shares are directly held by the Reporting Person's wife.

F2: The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.